Reuters logo
Valeant seeks to become top 5 pharmaceutical company -CEO
January 7, 2014 / 1:55 PM / 4 years ago

Valeant seeks to become top 5 pharmaceutical company -CEO

Jan 7 (Reuters) - Valeant Pharmaceuticals International Inc aims to crack the top-five ranks of drug companies by market capitalization by the end of 2016, Chief Executive Michael Pearson said on Tuesday.

Montreal, Quebec-based Valeant, which has a market cap of about $38.4 billion and sits among the top 15 pharmaceutical companies by that measure, would need to reach about $150 billion in market cap to crack the top five, Pearson said on a call with analysts and investors.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below